Related Experiment Video

Updated: Jun 17, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
09:57

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens

Published on: February 14, 2011

HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis

Alice M Ribeiro1, Anamelia L Bocca, André C Amaral

  • 1Laboratory of Pathology, Faculty of Medicine, University of Brasília, 70910-900 Brasilia, DF, Brazil.

Vaccine
|January 5, 2010
PubMed

Insights

DNAhsp65 immunotherapy offers a promising new treatment for paracoccidioidomycosis, a fungal infection common in Latin America. This approach reduced fungal load and lung damage in mice, suggesting potential for treating various mycoses.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Paracoccidioidomycosis is a prevalent Latin American fungal infection with challenging conventional treatments leading to relapses.
  • There is a critical need for novel therapeutic strategies to manage paracoccidioidomycosis and its sequelae.
  • Previous research indicated prophylactic benefits of the hsp65 gene from Mycobacterium leprae against murine paracoccidioidomycosis.

Purpose of the Study:

  • To evaluate the efficacy of DNAhsp65 immunotherapy in a murine model of paracoccidioidomycosis.
  • To assess the impact of DNAhsp65 immunotherapy on the immune response and fungal burden.

Main Methods:

  • BALB/c mice were infected with Paracoccidioides brasiliensis.
  • Mice were treated with DNAhsp65 immunotherapy.
  • Immune responses, specifically Th1 cytokine levels, were measured.
  • Fungal burden and pulmonary injury were assessed.

Main Results:

  • DNAhsp65 immunotherapy led to an increase in Th1 cytokine production.
  • A significant reduction in fungal burden was observed in treated mice.
  • Pulmonary injury associated with the infection was ameliorated.

Conclusions:

  • DNAhsp65 immunotherapy demonstrates therapeutic potential for paracoccidioidomycosis in a murine model.
  • This immunotherapy approach may offer new prospects for treating paracoccidioidomycosis and other fungal infections.
  • The induction of Th1 responses appears to be a key mechanism in the observed therapeutic effects.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...